COVID-19 Pandemic Burden in Severe Mental Disease Patients
NCT04357769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2021-02-03
Summary
Despite being originated in Wuhan, in the China mainland region of the Hubei, Italy has been the hardest-hit country in the world by the COVID-19 pandemic during the month of March.
Due to the uncontrollable spread of the contagion, the Italian Government has been forced to impose a series of restrictions and social distancing measures, culminating in the extension of lockdown to the entire Italian territory on March 8th.
During this period, the general population has been overwhelmed by feelings of worry, anxiety, and discomfort. The discomfort is reinforced by the lengthening of the lockdown, to the point that it may be considered as a mass model of chronic or subchronic mild stress.
The predictable effects of this stress on mental health have already been claimed, Post-traumatic symptoms were found in 7% among 285 Wuhan and surrounding cities' residents during the COVID-19 outbreak. A recent survey in the Italian general population reported similar outcomes.
In this context, the psychic conditions of the most fragile ones, i.e. those already affected by a severe mental disorder, represent a major concern. Having a history of psychiatric illness is regarded as one of the most relevant predictors of a negative psychological impact of quarantine. Patients with severe mental disorders may be among the hardest hit subjects, as they may be more vulnerable by the COVID-19 outbreak for a series of clinical and psychological factors. In the Italian context, the vulnerability of these patients may be increased by the lockdown of mental health services as a consequence of mass quarantine and optimization of health resources toward action to contrast COVID-19-related sanitary emergencies.
Despite several reports investigated the psychological effects of COVID-19 pandemic on health-care workers, COVID-19 affected people, or the general population, at the moment, no study has investigated the effects of the distress caused by fear of contagion and mass quarantine on severe mental disorder patients. The present study aimed at providing a first evaluation of anxiety, depressive, stress-related symptoms in these patients.
Conditions
- Psychological Distress
- COVID
- Severe Mental Disorder
Interventions
- OTHER
-
PSS (Perceived Stress Scale)
Self-administered scale for the evaluation of the stress perceived by the subject in the last weeks
- OTHER
-
GAD-7 (7-item Generalized Anxiety Disorder)
Self-administered scale for the evaluation of anxiety symptoms in the last weeks
- OTHER
-
PHQ-9 (9-item Patient Health Questionnaire)
Self-administered scale for the evaluation of depressive symptoms in the last weeks
- OTHER
-
SPEQ (Specific Psychotic Experiences Questionnaire) - Paranoia and Grandiosity Subscales
Self-administered scale for the evaluation of sub-threshold psychotic symptoms in the last weeks
- OTHER
-
Zaritt Burden Interview
Self-administered scale for the evaluation of severe mental disorder patients' caregiver burden
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-10
- Primary Completion
- 2020-04-20
- Completion
- 2020-04-25
Countries
- Italy
Study Locations
More Related Trials
-
A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis
NCT04568135 ·Status: UNKNOWN
-
Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)
NCT04384419 ·Status: COMPLETED
-
COVID-19 and Psychotic Symptoms in France
NCT04356885 ·Status: COMPLETED
-
Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study
NCT03434405 ·Status: COMPLETED ·Phase: NA
-
The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center
NCT05109572 ·Status: COMPLETED
-
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573 ·Status: RECRUITING ·Phase: PHASE3
-
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
NCT03652974 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Objective Cognitive Effort in Neuropsychological Evaluation of Psychotic Disorders
NCT06782672 ·Status: NOT_YET_RECRUITING
-
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders
NCT03671005 ·Status: TERMINATED ·Phase: NA
-
Outcomes and Discharge of Long-stay Psychiatric Patients
NCT01701765 ·Status: COMPLETED
-
Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders
NCT07092826 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19 & Psychiatry: A Retrospective Chart Review
NCT05244096 ·Status: ACTIVE_NOT_RECRUITING
-
Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P)
NCT07093671 ·Status: RECRUITING ·Phase: NA
-
A Comparison of Two Cognitive Batteries in People With Schizophrenia
NCT00499044 ·Status: COMPLETED ·Phase: NA
-
This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.
NCT07184710 ·Status: NOT_YET_RECRUITING
-
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
NCT02534363 ·Status: COMPLETED ·Phase: PHASE4
-
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
NCT00204061 ·Status: COMPLETED ·Phase: PHASE4
-
Metacognitive Training in Schizophrenia
NCT01029067 ·Status: COMPLETED ·Phase: NA
-
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
NCT06423651 ·Status: RECRUITING ·Phase: NA
-
Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic
NCT04823988 ·Status: COMPLETED
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis
NCT02974400 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Excellence in Italy's Residence for Execution of Security Measure
NCT06018298 ·Status: COMPLETED
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Mindfulness Intervention for People With Psychosis
NCT03501862 ·Status: COMPLETED ·Phase: NA